• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿侵袭性真菌感染及当前的治疗策略。

Invasive fungal infections in newborns and current management strategies.

机构信息

Section of Neonatology, Department of Pediatrics, Texas Children's Hospital & Baylor College of Medicine, Houston, TX, USA.

出版信息

Expert Rev Anti Infect Ther. 2013 Jul;11(7):709-21. doi: 10.1586/14787210.2013.811925. Epub 2013 Jul 5.

DOI:10.1586/14787210.2013.811925
PMID:23829639
Abstract

Invasive fungal infections due to Candida are the third most common late-onset infection in infants born with birth weight <1500 g. Invasive candidiasis in infants born with birth weight <1000 g is associated with a 30% mortality and with neurodevelopmental impairment in more than half the survivors. A high degree of suspicion and a thorough multisystem evaluation is necessary for diagnosis of invasive fungal infections and to detect complications or sequalae. Amphotericin B deoxycholate is the mainstay in the treatment of invasive fungal infections in newborns. Early initiation of enteral feeds with human milk, decreasing dependence on catheters and avoidance of antacids, steroids and broad-spectrum antibiotics are the recommended preventive measures. Fluconazole prophylaxis should be targeted towards neonates born with <1000 g in neonatal units where baseline rates of invasive candidiasis are more than 5%.

摘要

由念珠菌引起的侵袭性真菌感染是出生体重<1500g 的婴儿中第三大常见的迟发性感染。出生体重<1000g 的婴儿侵袭性念珠菌病与 30%的死亡率相关,且超过一半的幸存者存在神经发育损伤。高度怀疑和彻底的多系统评估对于侵袭性真菌感染的诊断以及发现并发症或后遗症是必要的。两性霉素 B 去氧胆酸盐是新生儿侵袭性真菌感染治疗的基础。早期开始用母乳喂养,减少对导管的依赖,并避免使用抗酸剂、类固醇和广谱抗生素,这些是推荐的预防措施。氟康唑预防应针对出生体重<1000g 的新生儿,且在侵袭性念珠菌病基线率>5%的新生儿病房中进行。

相似文献

1
Invasive fungal infections in newborns and current management strategies.新生儿侵袭性真菌感染及当前的治疗策略。
Expert Rev Anti Infect Ther. 2013 Jul;11(7):709-21. doi: 10.1586/14787210.2013.811925. Epub 2013 Jul 5.
2
[Invasive candidiasis in neonatal intensive care units].新生儿重症监护病房中的侵袭性念珠菌病
Arch Pediatr. 2011 May;18 Suppl 1:S22-32. doi: 10.1016/S0929-693X(11)70937-X.
3
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.重症监护病房中的侵袭性念珠菌病:基于证据且处于证据边缘
Mycoses. 2008 Sep;51 Suppl 2:25-45. doi: 10.1111/j.1439-0507.2008.01571.x.
4
Candida infections in non-neutropenic children after the neonatal period.新生儿期后非中性粒细胞减少患儿的念珠菌感染。
Expert Rev Anti Infect Ther. 2011 Oct;9(10):923-40. doi: 10.1586/eri.11.104.
5
Advances in the treatment of invasive neonatal candidiasis.侵袭性新生儿念珠菌病的治疗进展
Expert Opin Pharmacother. 2015 May;16(7):1035-48. doi: 10.1517/14656566.2015.1031108. Epub 2015 Apr 5.
6
Antifungal therapy and outcomes in infants with invasive Candida infections.婴儿侵袭性念珠菌感染的抗真菌治疗及结局。
Pediatr Infect Dis J. 2012 May;31(5):439-43. doi: 10.1097/INF.0b013e3182467a72.
7
Echinocandin use in the neonatal intensive care unit.棘白菌素类药物在新生儿重症监护病房的应用。
Ann Pharmacother. 2012 Jan;46(1):108-16. doi: 10.1345/aph.1Q346. Epub 2011 Dec 20.
8
Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.棘白菌素类药物治疗儿童侵袭性念珠菌病的疗效和安全性:一项荟萃分析。
Pediatr Infect Dis J. 2019 Jan;38(1):42-49. doi: 10.1097/INF.0000000000002032.
9
What is the current and future status of conventional amphotericin B?传统两性霉素B的现状及未来发展趋势如何?
Int J Antimicrob Agents. 2006 Jun;27 Suppl 1:12-6. doi: 10.1016/j.ijantimicag.2006.03.013. Epub 2006 May 16.
10
Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications.重新审视两性霉素B脱氧胆酸盐用于重症监护病房患者念珠菌病的治疗:医学、伦理及财务影响
Am J Respir Crit Care Med. 2013 Mar 15;187(6):661-3. doi: 10.1164/ajrccm.187.6.661.

引用本文的文献

1
Clinical features, risk factors, and outcomes of neonatal invasive candidiasis: a 20-case study series from a tertiary neonatal critical care unit in Oman.新生儿侵袭性念珠菌病的临床特征、危险因素及结局:阿曼一家三级新生儿重症监护病房的20例病例系列研究
Ital J Pediatr. 2025 May 22;51(1):153. doi: 10.1186/s13052-025-01952-6.
2
Invasive Fungal Infections in the Neonatal Intensive Care Unit.新生儿重症监护病房中的侵袭性真菌感染
Cureus. 2025 Feb 25;17(2):e79620. doi: 10.7759/cureus.79620. eCollection 2025 Feb.
3
Invasive Candida Infections in Neonatal Intensive Care Units: Risk Factors and New Insights in Prevention.
新生儿重症监护病房侵袭性念珠菌感染:危险因素及预防新见解
Pathogens. 2024 Aug 6;13(8):660. doi: 10.3390/pathogens13080660.
4
End-organ damage from neonatal invasive fungal infection: a 14-year retrospective study from a tertiary center in China.新生儿侵袭性真菌感染所致靶器官损害:中国一家三级中心的 14 年回顾性研究。
BMC Infect Dis. 2024 May 23;24(1):521. doi: 10.1186/s12879-024-09360-7.
5
Risk factors and clinical analysis of peripherally inserted central catheter-related fungal colonization in premature infants.早产儿外周置入中心静脉导管相关真菌定植的危险因素及临床分析。
Sci Rep. 2021 Oct 22;11(1):20897. doi: 10.1038/s41598-021-00120-0.
6
Introducing multi-modal enteral medication reduced morbidity and mortality associated with necrotising enterocolitis.引入多模式肠内给药可降低与坏死性小肠结肠炎相关的发病率和死亡率。
Acta Paediatr. 2021 Feb;110(2):458-464. doi: 10.1111/apa.15466. Epub 2020 Jul 22.
7
Cross-sectional study of drug utilisation in a Chinese neonatal unit.中国新生儿病房药物利用的横断面研究。
J Int Med Res. 2020 May;48(5):300060520914197. doi: 10.1177/0300060520914197.
8
Advances in the Treatment of Mycoses in Pediatric Patients.儿科患者真菌病治疗的进展
J Fungi (Basel). 2018 Oct 11;4(4):115. doi: 10.3390/jof4040115.
9
Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis.他克莫司与伏立康唑相互作用,通过抑制干扰素相关的炎症反应来减轻真菌性角膜炎的严重程度,同时使用他克莫司和伏立康唑治疗可抑制真菌性角膜炎。
Mol Vis. 2018 Mar 4;24:187-200. eCollection 2018.
10
Indoor airborne fungal pollution in newborn units in Turkey.土耳其新生儿病房的室内空气真菌污染
Environ Monit Assess. 2017 Jul;189(7):362. doi: 10.1007/s10661-017-6051-y. Epub 2017 Jun 30.